PLACENTAL TRANSPORT PROTEINS AND FETAL GROWTH RESTRICTION: A BIOCHEMISTRY–PHYSIOLOGY INTERFACE

Main Article Content

Dr Farida Mujahid
Dr Hina Umair
Dr Gulnaz Begum
Dr Ommia Kalsoom
Dr Muhammad Razaq
Dr Uzma Faryal

Keywords

Placental transport proteins, Fetal growth restriction, GLUT, SNAT, LAT, FATP, ABC transporters, Placental morphology, Neonatal outcomes

Abstract

To investigate the relationship between placental transport protein expression and fetal growth restriction, highlighting the biochemical physiological mechanisms linking placental function to neonatal outcomes.


Methods


A prospective observational study was conducted at Khyber Girls Medical College, Peshawar, from January 2023 to January 2024. Seventy-three women were enrolled and categorized into FGR (n=35) and appropriate-for-gestational-age (AGA) groups (n=38). Maternal demographics, neonatal outcomes, and placental morphology were recorded. Placental samples were analyzed for the expression of glucose transporters (GLUT1, GLUT3), amino acid transporters (SNAT2, LAT1), fatty acid transport proteins (FATP, CD36), and ABC transporters (P-gp, BCRP) using qRT-PCR and Western blotting.


Results


Mothers of FGR neonates showed a higher frequency of hypertensive disorders (p=0.02). Neonates in the FGR group had significantly lower birth weight, length, and head circumference compared to controls (p<0.001). Placental weight and thickness were reduced, with infarcts and calcifications more common in FGR cases. Expression of GLUT1, GLUT3, SNAT2, LAT1, FATP, and CD36 was significantly downregulated in the FGR group (p<0.001), while P-gp and BCRP were upregulated (p<0.001).


Conclusion


Altered expression of placental transport proteins is strongly associated with fetal growth restriction. Reduced nutrient transporter activity coupled with increased efflux transporter expression may impair fetal supply, contributing to restricted growth. These findings underscore the importance of placental biochemistry in fetal outcomes and suggest potential avenues for therapeutic intervention.

Abstract 62 | PDF Downloads 20

References

Morley, L., et al., Placental blood flow sensing and regulation in fetal growth restriction. 2021. 113: p. 23-28.
2. Zur, R.L., et al., The placental basis of fetal growth restriction. 2020. 47(1): p. 81-98.
3. O'Brien, K. and Y.J.A.R.o.N. Wang, The placenta: a maternofetal interface. 2023. 43(1): p. 301-325.
4. Yang, Z., et al., Altered distribution of fatty acid exerting lipid metabolism and transport at the maternal-fetal interface in fetal growth restriction. 2023. 139: p. 159-171.
5. Ortega, M.A., et al., The pivotal role of the placenta in normal and pathological pregnancies: a focus on preeclampsia, fetal growth restriction, and maternal chronic venous disease. 2022. 11(3): p. 568.
6. Zhou, H., et al., Regulators involved in trophoblast syncytialization in the placenta of intrauterine growth restriction. 2023. 14: p. 1107182.
7. Edwards, A.K., et al., Identification of pathways associated with placental adaptation to maternal nutrient restriction in sheep. 2020. 11(9): p. 1031.
8. Tsai, K., et al., Differential expression of mTOR related molecules in the placenta from gestational diabetes mellitus (GDM), intrauterine growth restriction (IUGR) and preeclampsia patients. 2021. 21(2): p. 100503.
9. Sanches, A.P.V., et al., Obesity phenotype induced by high-fat diet leads to maternal-fetal constraint, placental inefficiency, and fetal growth restriction in mice. 2022. 104: p. 108977.
10. Martín-Estal, I., et al., The placenta as a target for alcohol during pregnancy: The close relation with IGFs signaling pathway. 2021: p. 119-153.
11. Pendleton, A.L., et al., Lower oxygen consumption and Complex I activity in mitochondria isolated from skeletal muscle of fetal sheep with intrauterine growth restriction. 2020. 319(1): p. E67-E80.
12. Sibiak, R., et al., Fetomaternal expression of glucose transporters (GLUTs)—biochemical, cellular and clinical aspects. 2022. 14(10): p. 2025.
13. Abad, C., et al., Maternal-fetal interface: new insight in placenta research. 2023, Frontiers Media SA. p. 1325568.
14. Kallol, S. and C.J.B.S.T. Albrecht, Materno-fetal cholesterol transport during pregnancy. 2020. 48(3): p. 775-786.
15. Kajdy, A., et al., Evidence of placental aging in late SGA, fetal growth restriction and stillbirth—a systematic review. 2023. 11(7): p. 1785.
16. Hong, J. and S.J.C.S. Kumar, Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction. 2023. 137(8): p. 579-595.
17. Xiong, Y.-W., et al., Maternal cadmium exposure during late pregnancy causes fetal growth restriction via inhibiting placental progesterone synthesis. 2020. 187: p. 109879.
18. Liu, S., et al., Maternal high-fructose consumption provokes placental oxidative stress resulting in asymmetrical fetal growth restriction in rats. 2021. 69(1): p. 68-76.
19. Abascal-Saiz, A., et al., Decreased fatty acid oxidation gene expression in pre-eclampsia according to the onset and presence of intrauterine growth restriction. 2023. 15(18): p. 3877.
20. Ganguly, E., et al., Organic anion transporting polypeptide 2B1 in human fetal membranes: a novel gatekeeper for drug transport during pregnancy? 2021. 12: p. 771818.

Most read articles by the same author(s)